Alan F. Denenberg
ΒιΆΉΘλΏΪ
Filters
Denali Therapeutics $400 million at-the-market offering
The shares are listed on the Nasdaq Global Select Market
Recursion Pharmaceuticals $500 million at-the-market offering
The shares are listed on the Nasdaq Global Select Market
Cisco Systems $5 billion notes offering
The investment-grade offering comprises five tranches of notes
NeuroPace $74.75 million follow-on offering
The stock is listed on the Nasdaq Global Market
McKesson $850 million acquisition of controlling interest in PRISM Vision
We are advising McKesson on the transaction
Maze Therapeutics $140 million IPO
The shares are listed on Nasdaq
Olema Pharmaceuticals $150 million at-the-market offering
The shares are listed on the Nasdaq Global Select Market
Personalis $50 million at-the-market offering
The shares are listed on the Nasdaq Global Market
Nutanix $862.5 million convertible senior notes offering
The 0.5% convertible senior notes are due 2029
MARA Holdings $850 million convertible notes offering
The convertible notes are due 2031